$QMCO
QUANTUM CORP /DE/ Stock $qmco

$qmco Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000120677414002410 Filed on August 08, 2014

Income Statement

Concept	2014 Q2	2013 Q2
Revenue	$128.1M	$147.8M
YoY Change	-13.34%	4.97%
Cost Of Revenue	$72.60M	$78.01M
YoY Change	-6.94%	-8.28%
Gross Profit	$55.53M	$69.84M
YoY Change	-20.49%	25.17%
Gross Profit Margin	43.34%	47.23%
Selling, General & Admin	$42.08M	$44.85M
YoY Change	-6.18%	-12.38%
% of Gross Profit	75.78%	64.22%
Research & Development	$14.55M	$16.69M
YoY Change	-12.82%	-10.0%
% of Gross Profit	26.21%	23.9%
Depreciation & Amortization	$2.198M	$2.872M
YoY Change	-23.47%	-4.93%
% of Gross Profit	3.96%	4.11%
Operating Expenses	$57.50M	$64.10M
YoY Change	-10.3%	-8.08%
Operating Profit	-$1.507M	$5.735M
YoY Change	-126.28%	-141.14%
Interest Expense	$2.444M	$2.439M
YoY Change	0.21%	31.91%
% of Operating Profit		42.53%
Other Income/Expense, Net	-$125.0K	$375.0K
YoY Change	-133.33%	-210.95%
Pretax Income	-$4.076M	$3.671M
YoY Change	-211.03%	-122.76%
Income Tax	$248.0K	$390.0K
% Of Pretax Income		10.62%
Net Earnings	-$4.324M	$3.281M
YoY Change	-231.79%	-119.73%
Net Earnings / Revenue	-3.37%	2.22%
Basic Earnings Per Share	-$0.02
Diluted Earnings Per Share	-$0.02	$0.01
COMMON SHARES
Basic Shares Outstanding	250.7M shares	243.3M shares
Diluted Shares Outstanding	250.7M shares	245.8M shares

Balance Sheet

Concept	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$104.5M	$76.70M
YoY Change	36.25%	65.66%
Cash & Equivalents	$104.5M	$76.73M
Short-Term Investments
Other Short-Term Assets	$10.88M	$12.76M
YoY Change	-14.74%	-38.95%
Inventory	$57.90M	$83.20M
Prepaid Expenses
Receivables	$90.47M	$86.97M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$266.5M	$262.7M
YoY Change	1.43%	2.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.26M	$20.22M
YoY Change	-14.61%	-20.09%
Goodwill	$55.61M	$55.61M
YoY Change	0.0%
Intangibles		$10.59M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.19M	$9.264M
YoY Change	10.02%	44.75%
Total Long-Term Assets	$84.74M	$95.68M
YoY Change	-11.43%	-11.81%
TOTAL ASSETS
Total Short-Term Assets	$266.5M	$262.7M
Total Long-Term Assets	$84.74M	$95.68M
Total Assets	$351.2M	$358.4M
YoY Change	-2.01%	-1.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.78M	$35.27M
YoY Change	9.94%	-25.58%
Accrued Expenses	$51.10M	$58.60M
YoY Change	-12.8%	-0.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$183.3M	$182.2M
YoY Change	0.64%	-5.71%
LONG-TERM LIABILITIES
Long-Term Debt	$203.7M	$205.0M
YoY Change	-0.63%	11.11%
Other Long-Term Liabilities	$10.41M	$9.540M
YoY Change	9.09%	-77.71%
Total Long-Term Liabilities	$256.5M	$253.6M
YoY Change	1.15%	11.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$183.3M	$182.2M
Total Long-Term Liabilities	$256.5M	$253.6M
Total Liabilities	$439.8M	$435.7M
YoY Change	0.94%	2.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$544.4M	-$516.6M
YoY Change	5.38%
Common Stock	$449.1M	$433.3M
YoY Change	3.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$88.59M	-$77.31M
YoY Change
Total Liabilities & Shareholders Equity	$351.2M	$358.4M
YoY Change	-2.01%	-1.67%

Cashflow Statement

Concept	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	-$4.324M	$3.281M
YoY Change	-231.79%	-119.73%
Depreciation, Depletion And Amortization	$2.198M	$2.872M
YoY Change	-23.47%	-4.93%
Cash From Operating Activities	$6.274M	$9.173M
YoY Change	-31.6%	-927.14%
INVESTING ACTIVITIES
Capital Expenditures	$1.371M	$1.230M
YoY Change	11.46%	-69.13%
Acquisitions
YoY Change
Other Investing Activities	$400.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$929.0K	-$1.267M
YoY Change	-26.68%	-65.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$114.0K	$60.00K
YoY Change	90.0%	-65.91%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$5.000K	-$143.0K
YoY Change	-96.5%	-1.38%
NET CHANGE
Cash From Operating Activities	$6.274M	$9.173M
Cash From Investing Activities	-$929.0K	-$1.267M
Cash From Financing Activities	-$5.000K	-$143.0K
Net Change In Cash	$5.340M	$7.763M
YoY Change	-31.21%	-257.75%
FREE CASH FLOW
Cash From Operating Activities	$6.274M	$9.173M
Capital Expenditures	$1.371M	$1.230M
Free Cash Flow	$4.903M	$7.943M
YoY Change	-38.27%	-255.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	dei	Amendment Flag AmendmentFlag	false
CY2014Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2014Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2014Q2	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
CY2014Q2	dei	Document Type DocumentType	10-Q
CY2014Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000709283
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	253840119	shares
CY2014Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q2	dei	Entity Registrant Name EntityRegistrantName	QUANTUM CORP /DE/
CY2014Q2	dei	Trading Symbol TradingSymbol	QTM
CY2014Q2	qtm	Dilutive Common Share Equivalents From Espp DilutiveCommonShareEquivalentsFromEspp		shares
CY2013Q2	qtm	Dilutive Common Share Equivalents From Espp DilutiveCommonShareEquivalentsFromEspp	72000	shares
CY2014Q2	qtm	Dilutive Common Share Equivalents From Stock Plans DilutiveCommonShareEquivalentsFromStockPlans		shares
CY2013Q2	qtm	Dilutive Common Share Equivalents From Stock Plans DilutiveCommonShareEquivalentsFromStockPlans	2463000	shares
CY2014Q2	qtm	Increase Decrease In Manufacturing Inventories Net IncreaseDecreaseInManufacturingInventoriesNet	-597000	USD
CY2013Q2	qtm	Increase Decrease In Manufacturing Inventories Net IncreaseDecreaseInManufacturingInventoriesNet	-337000	USD
CY2014Q2	qtm	Increase Decrease In Service Parts Inventories Net IncreaseDecreaseInServicePartsInventoriesNet	63000	USD
CY2013Q2	qtm	Increase Decrease In Service Parts Inventories Net IncreaseDecreaseInServicePartsInventoriesNet	-913000	USD
CY2014Q2	qtm	Manufacturing Inventories Net ManufacturingInventoriesNet	33122000	USD
CY2014Q1	qtm	Manufacturing Inventories Net ManufacturingInventoriesNet	34815000	USD
CY2014Q2	qtm	Restructuring Charges To Operating Expense RestructuringChargesToOperatingExpense	865000	USD
CY2013Q2	qtm	Restructuring Charges To Operating Expense RestructuringChargesToOperatingExpense	2559000	USD
CY2014Q2	qtm	Service Parts Inventories ServicePartsInventories	24787000	USD
CY2014Q1	qtm	Service Parts Inventories ServicePartsInventories	25629000	USD
CY2014Q2	qtm	Service Parts Inventory Component Parts ServicePartsInventoryComponentParts	8316000	USD
CY2014Q1	qtm	Service Parts Inventory Component Parts ServicePartsInventoryComponentParts	7703000	USD
CY2014Q2	qtm	Service Parts Inventory Finished Goods ServicePartsInventoryFinishedGoods	16471000	USD
CY2014Q1	qtm	Service Parts Inventory Finished Goods ServicePartsInventoryFinishedGoods	17926000	USD
CY2014Q2	qtm	Service Parts Inventory Write Down ServicePartsInventoryWriteDown	1154000	USD
CY2013Q2	qtm	Service Parts Inventory Write Down ServicePartsInventoryWriteDown	4028000	USD
CY2014Q2	qtm	Stock Purchase Plan Expense StockPurchasePlanExpense	213000	USD
CY2013Q2	qtm	Stock Purchase Plan Expense StockPurchasePlanExpense	386000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	38780000	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	41792000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	90465000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	101605000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6687000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6620000	USD
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	446606000	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	443547000	USD
CY2014Q2	us-gaap	Adjustment For Long Term Intercompany Transactions Net Of Tax AdjustmentForLongTermIntercompanyTransactionsNetOfTax	58000	USD
CY2013Q2	us-gaap	Adjustment For Long Term Intercompany Transactions Net Of Tax AdjustmentForLongTermIntercompanyTransactionsNetOfTax	-64000	USD
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	111000	USD
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	88000	USD
CY2014Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	411000	USD
CY2013Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	409000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2234000	USD
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2224000	USD
CY2014Q2	us-gaap	Assets Assets	351216000	USD
CY2014Q1	us-gaap	Assets Assets	361798000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	266472000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	274095000	USD
CY2014Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	84744000	USD
CY2014Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	87703000	USD
CY2014Q2	us-gaap	Business Exit Costs1 BusinessExitCosts1	727000	USD
CY2013Q2	us-gaap	Business Exit Costs1 BusinessExitCosts1	76000	USD
CY2014Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	302000	USD
CY2013Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	746000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104464000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99125000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76731000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68976000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5339000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7755000	USD
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	250810000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	250410000	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	250810000	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	250410000	shares
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	2508000	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	2504000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4257000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3148000	USD
CY2014Q2	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	203735000	USD
CY2014Q1	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	203735000	USD
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	54908000	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	58783000	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	72602000	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	78014000	USD
CY2014Q2	us-gaap	Cost Of Services CostOfServices	17694000	USD
CY2013Q2	us-gaap	Cost Of Services CostOfServices	19231000	USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	93426000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	98098000	USD
CY2014Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	38280000	USD
CY2014Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	40054000	USD
CY2014Q2	us-gaap	Depreciation Depreciation	2198000	USD
CY2013Q2	us-gaap	Depreciation Depreciation	2872000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.01
CY2014Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1000	USD
CY2013Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-8000	USD
CY2014Q2	us-gaap	Effect On Future Cash Flows Amount EffectOnFutureCashFlowsAmount	7466000	USD
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26559000	USD
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25036000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	257717000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	255483000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	259394000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	259394000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1677000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3911000	USD
CY2014Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	462000	USD
CY2013Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14371000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14689000	USD
CY2014Q2	us-gaap	Goodwill Goodwill	55613000	USD
CY2014Q1	us-gaap	Goodwill Goodwill	55613000	USD
CY2014Q2	us-gaap	Goodwill Gross GoodwillGross	394613000	USD
CY2014Q1	us-gaap	Goodwill Gross GoodwillGross	394613000	USD
CY2014Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	339000000	USD
CY2014Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	339000000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	55526000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	69835000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4076000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3671000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	248000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	390000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3010000	USD
CY2013Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12372000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11140000	USD
CY2013Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10699000	USD
CY2014Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	77000	USD
CY2013Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-128000	USD
CY2014Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-6446000	USD
CY2013Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2169000	USD
CY2014Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1549000	USD
CY2013Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2370000	USD
CY2014Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	291000	USD
CY2013Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2684000	USD
CY2014Q2	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	20000	USD
CY2013Q2	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	37000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	2444000	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	2439000	USD
CY2014Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19430000	USD
CY2014Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	18069000	USD
CY2014Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	13422000	USD
CY2014Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	15690000	USD
CY2014Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	270000	USD
CY2014Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1056000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	351216000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	361798000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	183341000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	190555000	USD
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	256469000	USD
CY2014Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	258643000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-143000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-929000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1267000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6274000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9173000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-4324000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	3281000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	57495000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	64100000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1507000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5735000	USD
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	15259000	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	15168000	USD
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	10879000	USD
CY2014Q1	us-gaap	Other Assets Current OtherAssetsCurrent	10161000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10192000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10605000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-69000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	67000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-133000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10407000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10831000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-125000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	375000	USD
CY2014Q2	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-259000	USD
CY2013Q2	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		USD
CY2014Q2	us-gaap	Other Restructuring Costs OtherRestructuringCosts	13000	USD
CY2013Q2	us-gaap	Other Restructuring Costs OtherRestructuringCosts		USD
CY2014Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	2026000	USD
CY2014Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	119000	USD
CY2013Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	203000	USD
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1371000	USD
CY2013Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1230000	USD
CY2014Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	114000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	60000	USD
CY2014Q2	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	462000	USD
CY2013Q2	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17262000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17574000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14554000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16694000	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2755000	USD
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2760000	USD
CY2014Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	2698000	USD
CY2013Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	2738000	USD
CY2014Q2	us-gaap	Restructuring Charges RestructuringCharges	865000	USD
CY2013Q2	us-gaap	Restructuring Charges RestructuringCharges	2559000	USD
CY2014Q2	us-gaap	Restructuring Costs RestructuringCosts	1006000	USD
CY2014Q2	us-gaap	Restructuring Reserve RestructuringReserve	7466000	USD
CY2014Q1	us-gaap	Restructuring Reserve RestructuringReserve	8368000	USD
CY2014Q2	us-gaap	Restructuring Reserve Accrual Adjustment RestructuringReserveAccrualAdjustment	141000	USD
CY2014Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3419000	USD
CY2014Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	4345000	USD
CY2014Q2	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	4047000	USD
CY2014Q1	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	4023000	USD
CY2014Q2	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-927000	USD
CY2013Q2	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	1026000	USD
CY2014Q2	us-gaap	Restructuring Reserve Settled Without Cash1 RestructuringReserveSettledWithoutCash1	259000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-544395000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-540071000	USD
CY2014Q2	us-gaap	Revenues Revenues	128128000	USD
CY2013Q2	us-gaap	Revenues Revenues	147849000	USD
CY2014Q2	us-gaap	Royalty Revenue RoyaltyRevenue	9434000	USD
CY2013Q2	us-gaap	Royalty Revenue RoyaltyRevenue	25508000	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	80194000	USD
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	85849000	USD
CY2014Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	38500000	USD
CY2013Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	36492000	USD
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	27705000	USD
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	30158000	USD
CY2014Q2	us-gaap	Severance Costs1 SeveranceCosts1	125000	USD
CY2013Q2	us-gaap	Severance Costs1 SeveranceCosts1	2483000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3068000	USD
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3356000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	128000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.80
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	299000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.21
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.32
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	11914000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	12108000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.78
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.80
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	365000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.87
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.54
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y29D
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1223000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	58000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	949000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6582000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7997000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.58
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.78
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y1M21D
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	949000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6311000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	949000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6572000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.58
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y1M21D
CY2014Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.85
CY2014Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.95
CY2014Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.39
CY2014Q2	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	5898000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	6116000	USD
CY2013Q2	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	7015000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	7520000	USD
CY2014Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	2329000	USD
CY2013Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	2587000	USD
CY2014Q2	us-gaap	Standard Product Warranty Accrual Period Increase Decrease StandardProductWarrantyAccrualPeriodIncreaseDecrease	-218000	USD
CY2013Q2	us-gaap	Standard Product Warranty Accrual Period Increase Decrease StandardProductWarrantyAccrualPeriodIncreaseDecrease	-505000	USD
CY2014Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	383000	USD
CY2013Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-60000	USD
CY2014Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1728000	USD
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	245844000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	250666000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	243309000	shares
CY2013Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2142000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	-88594000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	-87400000	USD
CY2014Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	134000	shares
CY2014Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	157000	USD
CY2013Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	232000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	250666000	shares

Files In Submission

Name	View Source	Status
0001206774-14-002410-index-headers.html	Edgar Link	pending
0001206774-14-002410-index.html	Edgar Link	pending
0001206774-14-002410.txt	Edgar Link	pending
0001206774-14-002410-xbrl.zip	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
qtm-20140630.xml	Edgar Link	completed
qtm-20140630.xsd	Edgar Link	pending
qtm-20140630_cal.xml	Edgar Link	unprocessable
qtm-20140630_def.xml	Edgar Link	unprocessable
qtm-20140630_lab.xml	Edgar Link	unprocessable
qtm-20140630_pre.xml	Edgar Link	unprocessable
quantum_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QMCO
QUANTUM CORP /DE/ Stock $qmco

2014 Q2 Form 10-Q Financial Statement

#000120677414002410 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QMCO QUANTUM CORP /DE/ Stock $qmco

2014 Q2 Form 10-Q Financial Statement

#000120677414002410 Filed on August 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QMCO
QUANTUM CORP /DE/ Stock $qmco